• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Asssessment and Risk Stratification for Bleeding Ulcers


ACG recommendations for overt upper GI bleeding include assessment of hemodynamic status and initiation of resuscitative measures, as needed, as a first step.

American College of Gastroenterology recommendations for initial assessment and risk stratification for patients with ulcer bleeding include which of the following?

a. Hemodynamic status should be assessed immediately on presentation and resuscitative measures begun as needed.
b. Blood transfusions should target hemoglobin 7 g/dL or greater, with higher hemoglobin levels targeted in patients with clinical evidence of intravascular volume depletion or comorbidities.
c. Risk assessment should be performed to stratify patients into higher and lower risk categories and may assist in initial decisions, such as timing of endoscopy, time of discharge, and level of care.
d. A, B, and C


The first step in management of patients who present with overt upper GI bleeding is assessment of hemodynamic status and initiation of resuscitative measures as needed. In addition to intravenous fluids, transfusion of red blood cells may be required. Risk assessment is clinically useful to determine which patients are at higher risk for further bleeding or death.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.